A 4449 New Jersey General Assembly · 2026-2027 Regular Session

Requires DOBI to review hormone replacement therapy coverage.

This bill requires New Jersey's Department of Banking and Insurance (DOBI) to conduct a one-time confidential review of health insurance coverage for hormone replacement therapy (HRT). The review will examine how insurers administer HRT coverage under the "New Jersey Menopause Coverage Act" and whether there has been an aggregate increase in coverage since that law took effect. DOBI will analyze data on prior authorization and step therapy decisions for HRT, as well as other insurer-collected information, and must report its findings to the Legislature within six months. This review directly affects health insurance carriers (by requiring them to provide data) and DOBI (as the reviewing agency), but does not change current coverage requirements.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2026
Committee Review
Floor Vote
Governor
Introduced Feb 24, 2026 Last action Feb 24, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Feb 24, 2026
Introduced
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
lower
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Heather Simmons
Heather Simmons
DDemocratic
NJ
3